X39 Patch to Determine GHK-Cu Production Levels
The LifeWave X39 patch uses phototherapy to stimulate a rebalancing of the body. Based on data from other studies, it was felt that a possible change in the copper tripeptide GHK-Cu might be a factor in the effects produced by the patch. As a follow on to prior studies it was determined that a double blind study was an appropriate method of testing this theory.
What is GHK-Cu / Copper Peptide?
The GHK-Cu is known to be a peptide, which is a naturally occurring copper complex that has been first identified in the human plasma. It has also been found in different areas of the body, such as the saliva and the urine.
Copper peptides are usually small and are naturally occurring protein fragments. They have a high affinity for copper ions. Evidence even suggests that they are critical to normal body functions.
A lot of clinical studies have shown that GHK-Cu has different roles and benefits in the human body, including:
Wound healing
Stimulates Collagen
Repair protective skin barrier proteins
Attracting immune cells
Gives antioxidants
Promotes Blood Vessel Growth
Glycosaminoglycan synthesis in the skin fibroblasts
Double-Blind Testing of the Lifewave X39 Patch to Determine GHK-Cu Production Levels
This study explores the impact of wearing the LifeWave X39 nontransdermal photobiomodulation patch over the period of one week on levels of glycyl-L-histidyl-L-lysine-copper(2+) (GHK-Cu) levels in the blood in a double-blind randomized controlled trial. This particular tripeptide was first isolated by Dr. Loren Pickart in 1973. GHK-Cu is important as the “copper tripeptide-1 belongs to a group of emergency response molecules which are released during injury and come to the body’s aid...” [1] It is naturally sent by the body to any type of injury to tissue. For example: the “copper tripeptide-1 has been suggested to have a potential therapeutic role in age-related neurodegeneration and cognitive decline
Conclusion: This study explored the changes in amounts of GHK-Cu present in the blood as a result of wearing the LifeWave X39 patch 8-12 hours per day for 1 week. A significant increase in GHK-Cu concentration in the blood
Source: Connor CA, Connor MH, Yue D, Eickhoff J, Wagner S, et al. (2021) Double-Blind Testing of the Lifewave X39 Patch to Determine GHK-Cu Production Levels. Internal Med Res Open J Volume 6(1): 1-3.
Internal Med Res Open J, Volume 6(1): 3–3, 2021